Cases 1 - 10 of 4,728
Regeneron Pharmaceuticals, Inc. v. Amgen, Inc.
as 1:2024cv00039
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Counter Claimant:
Amgen, Inc.
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
In Re: Aflibercept Patent Litigation
as 1:2024md03103
Not Yet Classified:
AFLIBERCEPT PATENT LITIGATION
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals, Inc., AMGEN USA, INC., BIOCON BIOLOGICS INC. and others
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
Bausch Health Ireland Limited et al v. Mylan Pharmaceuticals Inc.
as 1:2024cv00036
Plaintiff:
Bausch Health Ireland Limited and Salix Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis Co., Ltd.
as 1:2023cv00106
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Samsung Bioepis Co., Ltd.
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Formycon AG
as 1:2023cv00097
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Formycon AG
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis, CO., LTD.,
as 1:2023cv00094
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Samsung Bioepis, CO., LTD.,
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc.
as 1:2023cv00089
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Celltrion, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Actelion Pharmaceuticals Ltd. et al v. Mylan Pharmaceuticals Inc.
as 1:2023cv00088
Plaintiff:
Actelion Pharmaceuticals Ltd. and Actelion Pharmaceuticals US, Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Abraxis Bioscience, LLC v. Mylan Pharmaceuticals, Inc.
as 1:2023cv00033
Counter Defendant:
Abraxis Bioscience, LLC
Defendant:
Mylan Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk, Inc. et al v. Viatris Inc. et al
as 1:2023cv00013
Plaintiff:
Novo Nordisk, Inc. and Novo Nordisk A/S
Defendant:
Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
